Clinical Trials
5 trialsNCT06904131 2025-04-01
A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors
Obstetrics & Gynecology Hospital of Fudan University
Phase NA Recruiting
NCT05101109 2024-07-31
Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL501 in Subjects With Any Progressive, Locally Advanced (Unresectable) or Metastatic Solid Tumors
ABL Bio, Inc.
Phase 1 Completed
NCT02298387 2020-08-11
A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors
Mereo BioPharma
Phase 1 Completed
NCT04076137 2019-09-03
Targeted T-cell Therapy in Solid Tumors
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT00149019 2011-04-08
Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.
Hadassah Medical Organization
Phase 2 Withdrawn